Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRC2.L Regulatory News (RC2)

  • There is currently no data for RC2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Convertible Loan Notes&Issue of Equity

23 Sep 2016 12:46

RNS Number : 7000K
Reconstruction Capital II Ltd
23 September 2016
 

23 September 2016

Reconstruction Capital II Limited

Exercise of Convertible Loan Notes and Issue of Equity

Reconstruction Capital II Limited ("the Company") announces that on 22 September 2016, it has received applications from holders of EUR 5,429,000 of convertible loan notes (each of which confers the right to receive 7.41 ordinary shares of EUR 0.01 each in the capital of the Company ("Ordinary Shares") for every EUR 1.0 face value of the convertible loan note) including, as follows:

(i) from Mr Dirk Van den Broeck, Chairman of the Company, a total of EUR 202,000 of convertible loan notes;

(ii) from Mr Ion Florescu, director of the investment adviser to the Company, a total of EUR 2,500,000 of convertible loan notes; and

(iii) from Reconstruction Management Limited, a Company in which Mr Florescu has an indirect beneficial interest, a total of EUR 1,062,000 of convertible loan notes.

Accordingly, the Company announces that it will be issuing and allotting 40,228,890 Ordinary Shares, subject to admission to trading. Application will be made for the new Ordinary Shares to be admitted to trading on AIM. It is expected that dealings in the new Ordinary Shares will commence at 8.00 a.m. on 11 October 2016 ("Admission").

Following Admission, Mr Ion Florescu is a beneficial owner either directly or indirectly of 81,391,311 Ordinary Shares, representing 54.99 per cent of the total issued share capital of the Company with voting rights.

Total Voting Rights

Following Admission the Company will have 148,006,537 Ordinary Shares in issue with voting rights. This figure of 148,006,537 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

The information contained within this announcement is considered to be inside information prior to its release as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

For further information, please contact:

Reconstruction Capital II Limited

Ion Florescu/Anca Moraru

Tel: +40 21 3167680

 

Grant Thornton UK LLP (Nominated Adviser)

Philip Secrett/Carolyn Sansom

Tel: +44 (0) 20 7383 5100

 

Panmure Gordon (UK) Limited (Broker)

Paul Fincham/Jonathan Becher

Tel: +44 (0) 20 7886 2500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELJMBTMBITBJF
Date   Source Headline
19th Dec 20237:00 amRNSCancellation - Reconstruction Capital II Limited
18th Dec 20237:00 amRNSDelisting and cancellation of trading
15th Dec 20233:32 pmRNSShare Dealing
12th Dec 20239:57 amRNSShare Dealing
8th Dec 202310:40 amRNSShare Dealing
29th Nov 202312:10 pmRNSResult of AGM
21st Nov 20239:34 amRNSShare Dealing
13th Nov 20234:21 pmRNSQuarterly Update
1st Nov 20237:00 amRNSProposed Cancellation & AGM Notice
31st Oct 202310:46 amRNSNet Asset Value and Policolor Material Error
28th Sep 202312:56 pmRNSLoan to Telecredit IFN S.A.
30th Aug 20239:46 amRNSInterim Unaudited Financial Statements
8th Aug 20232:45 pmRNSQuarterly Update
20th Jul 20239:21 amRNSNet Asset Value
23rd Jun 20235:00 pmRNSLoans to Telecredit IFN S.A.
9th Jun 202312:03 pmRNSAnnual Report and Audited Financial Statements
16th May 202311:25 amRNSNet Asset Value and Quarterly Report
11th Apr 20233:44 pmRNSNet Asset Value and Quarterly Report
30th Mar 20238:44 amRNSNew Valuations of Private Equity Positions
9th Jan 202312:38 pmRNSDirector Dealing
15th Dec 20228:59 amRNSLoan Facility
14th Nov 20224:59 pmRNSExtension of maturity date of loans to Telecredit
9th Nov 202212:56 pmRNSQuarterly Update
8th Nov 202211:34 amRNSJudgment in litigation against Romar
20th Oct 202211:31 amRNSNet Asset Value and Quarterly Report
5th Sep 202211:27 amRNSTransaction in Own Shares
17th Aug 20223:28 pmRNSInterim Unaudited Financial Statements
12th Aug 20223:55 pmRNSQuarterly Update
26th Jul 20222:23 pmRNSNet Asset Value
15th Jun 20227:00 amRNSAnnual Report and Audited Financial Statements
17th May 20222:56 pmRNSQuarterly Report
11th May 20222:43 pmRNSTransaction in Own Shares
10th May 20227:46 amRNSExtension of the maturity date of loans
4th May 20222:49 pmRNSNet Asset Value
14th Apr 202212:00 pmRNSNet Asset Value and Quarterly Report
6th Apr 202210:04 amRNSNew Valuations of Private Equity Positions
22nd Dec 20211:54 pmRNSLoans to Telecredit IFN S.A.
16th Nov 202110:06 amRNSQuarterly Report
16th Nov 20219:55 amRNSLoans to Telecredit IFN S.A.
20th Oct 202111:32 amRNSSeptember 2021 NAV Announcement
18th Oct 202112:14 pmRNSLoans to Telecredit IFN S.A.
9th Sep 20212:28 pmRNSDirector Appointment
17th Aug 20217:00 amRNSInterim Unaudited Financial Statements
9th Aug 20211:51 pmRNSQuarterly Report
28th Jul 20212:05 pmRNSNAV Announcement
28th Jul 20212:04 pmRNSDirector Resignation
7th Jun 202112:29 pmRNSAnnual Financial Report
11th May 20211:19 pmRNSQuarterly Report
11th May 20218:42 amRNSLoans to Telecredit IFN S.A.
4th May 202111:01 amRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.